1. United States
2. Tenn.
3. Letter

The FDA's new regulatory framework for COVID-19 vaccination is deeply concerning, as it will restrict access to updated vaccine boosters for many Americans. Requiring extensive clinical trials before approving shots for healthy adults under 65 is an unnecessary barrier that prioritizes bureaucracy over public health. Vaccines have proven to be safe and effective tools for preventing severe illness, hospitalizations, and deaths. Denying broad access to these life-saving boosters puts millions at risk and goes against established scientific evidence. While focused protection for high-risk groups is prudent, healthy individuals should maintain the option to get boosted against evolving virus strains. Multiple reputable studies have demonstrated the benefits of vaccination for all age groups. This heavy-handed approach disregards personal choice and credible data in favor of arduous approval processes that may delay immunization efforts. Public health decisions should be guided by science and aim to maximize protection, not erect arbitrary obstacles. I urge a reconsideration of these new rules to ensure all Americans can readily access COVID-19 vaccine boosters when needed and desired.